Indwelling catheter with stable enzyme coating

• US 5,868,720 A
• Filed: 08/03/1998
• Issued: 02/09/1999
• Est. Priority Date: 04/01/1994
• Status: Expired due to Term

• Current Assignee: Medtronic Minimed Incorporated (Medtronic Plc)
• Original Assignee: William P Van Antwerp
• Inventors: Van Antwerp, William P.
• Primary Examiner(s): YASKO JR, JOHN D
• Application Number:
  US09/127,839
• Time in Patent Office: 190 Days
• Field of Search: 604/264, 604/265, 604/266, 604/890.1, 604/891.1, 604/892.1, 424/422, 424/423, 424/426, 424/499, 435/177, 435/178, 435/180, 427/2.12, 427/2.28, 427/2.3
• US Class Current: 604/265
• CPC Class Codes: A61L 29/085 Macromolecular materials
• CPC Class Codes: A61M 25/0017 specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections

Abstract

An improved indwelling catheter adapted for long-term usage includes a stable enzyme coating to prevent occlusion of the catheter lumen. The enzyme coating includes a fibrinolytic and/or lipolytic enzyme incorporated in a catheter coating to resist or control proteolytic degradation, thereby maintaining the enzyme in an active state for dissolving clots and occlusions within the catheter lumen over an extended period of time.

Claims

1. A catheter for use in a body having bodily fluids of a patient, the catheter comprising:

an elongated tubular element formed from a polymeric material and adapted for placement in the body of the patient, the tubular element defining a catheter lumen and a surface; and

a long-term stabilized surface coating applied to the tubular element on at least a portion of the surface, the surface coating including at least one enzyme to dissolve occlusions along the catheter lumen and at least one coating material, and wherein the at least one coating material protects the enzyme and regulates degradation upon contact with the bodily fluids of the patient.

2. The catheter of claim 1, wherein the at least one enzyme is a fibrinolytic enzyme.

3. The catheter of claim 1, wherein the at least one enzyme is a lipolytic enzyme.

4. The catheter of claim 1, wherein the at least one enzyme is at least two different enzymes.

5. The catheter of claim 4, wherein the at least two different enzymes are selected from a group consisting of a fibrinolytic enzyme and a lipolytic enzyme.

6. The catheter of claim 5, wherein one of the at least two different enzymes is a fibrinolytic enzyme and a second of the at least two different enzymes is a lipolytic enzyme.

7. The catheter of claim 1, wherein the at least one enzyme comprises a combination of fibrinolytic and lipolytic enzymes.

8. The catheter of claim 1, wherein the at least one coating material is selected from a group of coating materials consisting of a porous encapsulant film, time release capsules and a serum protein.

9. The catheter of claim 8, wherein the at least one enzyme comprises a substantially micellar array of enzyme particles on the tubular element, and further wherein the at least one coating material is the porous encapsulant film covering the enzyme particles and adhering securely to the tubular element, the encapsulant film having a controlled porosity to permit diffusion passage of the bodily fluid constituents effective to activate the at least one enzyme for occlusion control while substantially shielding the enzyme to regulate degradation.

10. The catheter of claim 9, wherein the encapsulant film comprises dilute silicone rubber.

11. The catheter of claim 8, wherein the at least one coating materials is the time release capsules having the enzyme contained within an encapsulant shell of a material soluble in the presence of the bodily fluids of the patient, the time release capsules having a variable shell thickness for dissolution in the presence of the bodily fluids to expose the at least one enzyme over an extended period of time.

12. The catheter of claim 11, further including means for bonding the time release capsules to the tubular element.

13. The catheter of claim 11, wherein the encapsulant shell is formed from a soluble starch.

14. The catheter of claim 8, wherein the at least one coating materials is a membrane having the at least one enzyme cross linked with the serum protein and bonded to the tubular element.

15. The catheter of claim 14, wherein the at least one enzyme is cross linked with the serum protein by an aldehyde, and further including means for bonding the aldehyde to the tubular element.

16. The catheter of claim 8, wherein the at least one coating material is at least two different coating materials.

17. The catheter of claim 16, wherein one of the at least two different coating materials is the porous encapsulant film and another of the at least two different coating materials is the time release capsules.

18. The catheter of claim 16, wherein one of the at least two different coating materials is the porous encapsulant film and another of the at least two different coating materials is the serum protein.

19. The catheter of claim 16, wherein one of the at least two different coating materials is the serum protein and another of the at least two different coating materials is the time release capsules.